How to Buy Maplight Therapeutics Stock
Maplight Therapeutics Inc
MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for individuals grappling with severe central nervous system (CNS) disorders.
Maplight Therapeutics stock last closed at $13.00, down 5.69% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Maplight Therapeutics stock is currently +42.86% from its 52-week low of $9.10, and -67.85% from its 52-week high of $40.43.
As of Sep 11, 2026, there are 46.38M shares of MPLT outstanding. The market cap of MPLT is $602.91M. In the past 24 hours, 340,000 MPLT shares were traded.
How to Buy Maplight Therapeutics Stock
Wondering how to invest in Maplight Therapeutics stock? Here's how.
- Figure out where to buy Maplight Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you choose where to buy Maplight Therapeutics stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Fund your brokerage account: Choose your payment method and add your info.
- Analyze Maplight Therapeutics stock: The Maplight Therapeutics ticker symbol is MPLT. Is Maplight Therapeutics stock a good investment? Should you buy shares of MPLT? How do MPLT's underlying business fundamentals look? Do top analysts think Maplight Therapeutics is a good buy? Why has MPLT's stock price moved recently? (Hint: Our stock analysis website can help you figure out if MPLT is a good stock to buy).
- Place your MPLT trade: Decide if you will purchase MPLT shares at the current market price or use a limit order to buy MPLT shares at a particular price.
- Get key alerts regarding your MPLT investment: Create a watchlist to track your new investment in Maplight Therapeutics shares.
Step 1: Figure out where to buy Maplight Therapeutics stock
You will need an online brokerage account in order to access the NASDAQ market and buy MPLT shares.
Our favorite brokerage: eToro
Based on our experience, eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global markets: From Tech to Industrials, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've chosen the right brokerage, you'll need to fill out some personal info so you are able to invest in MPLT today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to open your new brokerage account.
- Submit your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have opened your account on the stock trading app, your next step is to transfer the money for your investment:
Watch the video below to see the process of transferring money into your new investment account.
Step 4: Analyze Maplight Therapeutics stock
After you have decided on the best place to buy Maplight Therapeutics stock, it's very important to research their stock before you buy, so you truly understand the risk and upside.
Maplight Therapeutics quick stats
Maplight Therapeutics Due Diligence Score
WallStreetZen was designed to help average investors perform more accurate fundamental analysis in less time.
You can see all of the due diligence checks on MPLT's stock page.
Is MPLT stock undervalued?
Analysts use many financial metrics, analyses, models, and charts to gauge MPLT's true value.
Using relative valuations ratios:
- MPLT may be undervalued based on its P/E ratio of 0.27x, relative to Biotechnology industry P/E ratio of 8.81x
- MPLT may be undervalued based on its P/B ratio of 1.73x, relative to Biotechnology industry P/B ratio of 5.32x
You can access more valuation research on MPLT's stock here.
MPLT Financial Overview
Positive Financial Indicators:
- There are more short-term assets than short-term liabilities on the MPLT balance sheet.
- MPLT has $304.93M in cash and short term investments. This is enough to cover its annual cash burn of $175.12M.
- MPLT has a low debt to equity ratio of 0.06.
- There are more short-term assets than long-term liabilities on the MPLT balance sheet.
- MPLT has cash burn of 175121000. It has sufficient cash and short-term investments to cover this for at least one year.
Do Wall Street analysts think it's a good time to buy Maplight Therapeutics stock
Out of 10 sell side analysts who give recommendations on MPLT, the consensus analyst rating on MPLT is a Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
Most Recent MPLT Analyst Recommendations
Malcolm Hoffman, a bottom 22% analyst from BMO Capital initiates coverage on MPLT with a buy rating and announces their MPLT price target of $46.00, on Jul 21, 2026.
Tiago Fauth, a top 16% analyst from Raymond James initiates coverage on MPLT with a strong buy rating and announces their MPLT price target of $46.00, on Jun 25, 2026.
Adam Vogel, a top 31% analyst from Craig-Hallum maintains MPLT with a buy rating and lowers their MPLT price target from $43.00 to $40.00, on Jun 23, 2026.
Paul Matteis, a top 24% analyst from Stifel Nicolaus maintains MPLT with a strong buy rating and raises their MPLT price target from $28.00 to $36.00, on Jun 2, 2026.
Joseph Thome, a bottom 6% analyst from TD Cowen initiates coverage on MPLT with a strong buy rating, on Apr 7, 2026.
You can dig deeper into what analysts are saying on the Maplight Therapeutics stock forecast page.
Metrics for Advanced MPLT Traders
What are MPLT executives and large shareholders up to?
In the past year, insiders at MPLT have bought more shares than they have sold.
Catalyst4 Inc, 10% Owner of MPLT, was the latest MPLT insider to buy. They bought $50,072,000.00 worth of MPLT stock on Aug 14, 2026.
Dig into more about who owns MPLT stock here.
Does MPLT provide a stable income stream?
No, Maplight Therapeutics doesn't provide an income stream by paying out dividends.
MPLT Social Trading Data
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Place your MPLT trade
You have two main order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are mostly fine for most investors. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a particular dollar amount, place a limit order.
Press the Open Trade button and your broker will place the order.
If you need more help investing in stocks on eToro, watch the helpful video below:
Step 6: Get key alerts regarding your MPLT investment
Now that you own some shares in MPLT, you'll want to stay up-to-date on your new shares.
Make a watchlist to see the latest developments about your MPLT stock.
MPLT Feed
How to Buy Stock in Maplight Therapeutics
To reiterate, here are the 6 steps you need to take to buy Maplight Therapeutics stock right now:
- Figure out where to buy Maplight Therapeutics stock
- Create your brokerage account
- Fund your brokerage account
- Analyze Maplight Therapeutics stock
- Place your MPLT trade
- Get key alerts regarding your MPLT investment
If you are looking for a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you want to monitor your investment in Maplight Therapeutics, hit the button below to create your watchlist.
Other Articles You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.